Spots Global Cancer Trial Database for refractory or relapsed
Every month we try and update this database with for refractory or relapsed cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma | NCT02056756 | Multiple Myelom... | Carfilzomib | 18 Years - | Stichting European Myeloma Network | |
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib | NCT03746912 | Acute Myeloid L... | Quizartinib Dih... | 18 Years - | Daiichi Sankyo | |
Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma | NCT00486564 | Neuroblastoma | Nifurtimox | - 21 Years | University of Vermont |